Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie – Państwowy Instytut Badawczy, do 2020 Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie – placówka onkologiczna i państwowy instytut badawczy. Wywodzi się z Instytutu Radowego, założonego w 1932 roku z inicjatywy Marii Skłodowskiej-Curie.

During the past decade, Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie; Oddzial Badan Wczesnych Faz conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie; Oddzial Badan Wczesnych Faz" #1 collaborator was "Foundation Medicine, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie; Oddzial Badan Wczesnych Faz" are "Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers" (1 trials), "Cancer of Unknown Primary Site" (1 trials), "Non-Small Cell Lung Cancer" (1 trials), "Solid Tumors" (1 trials) and "Solid Tumours" (1 trials). Many other conditions were trialed in "Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie; Oddzial Badan Wczesnych Faz" in a lesser frequency.

Most popular intervention types in "Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie; Oddzial Badan Wczesnych Faz" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Gemcitabine" (2 trials), "Alectinib" (1 trials), "Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie; Oddzial Badan Wczesnych Faz" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie; Oddzial Badan Wczesnych Faz". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie; Oddzial Badan Wczesnych Faz, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie; Oddzial Badan Wczesnych Faz, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".